EUVIMEDAtrasti EUVIMED
Crossref

Upregulation by duloxetine of the transforming growth factor‐α‐induced migration of hepatocellular carcinoma cells via enhancement of the c‐ Jun N‐terminal kinase activity

Rie Matsushima-Nishiwaki, Shota Kamoi, Osamu Kozawa

Cell Biochemistry and Function · 2023-10 · 41 (7) · 814-822

DOI: 10.1002/cbf.3831 ↗

At a glance

Journal article in Cell Biochemistry and Function, published online on 2023-07-25. Written by Rie Matsushima-Nishiwaki and 2 co-authors. Institution: Department of Pharmacology, Graduate School of Medicine, Gifu University, Gifu, Gifu Prefecture, Japan. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms. Cited 3 times so far (Crossref); 36 references. Funded by: Japan Society for the Promotion of Science.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Duloxetine, a selective reuptake inhibitor for serotonin and norepinephrine, is a medication widely used for major depression. Currently, duloxetine is also recommended for pain related to chemotherapy‐induced peripheral neuropathy or cancer. Previously, we showed that transforming growth factor‐α (TGF‐α) induces the migration of human hepatocellular carcinoma (HCC)‐derived HuH7 cells through the activation of c‐Jun N‐terminal kinase (JNK), p38 mitogen‐activated protein kinase (MAPK) and AKT. In the present study, we investigate whether duloxetine affects cell migration and its mechanism. Duloxetine significantly enhanced the TGF‐α‐induced migration of HuH7 cells. Fluvoxamine and sertraline, specific inhibitors of serotonin reuptake, also upregulated the TGF‐α‐induced cell migration. On the contrary, reboxetine, a specific norepinephrine reuptake inhibitor, failed to affect cell migration. Duloxetine significantly amplified the TGF‐α‐stimulated phosphorylation of JNK, but not p38 MAPK and AKT. In addition, fluvoxamine and sertraline, but not reboxetine, enhanced the phosphorylation of JNK. SP600125, a JNK inhibitor, suppressed the enhancement by duloxetine, fluvoxamine, or sertraline of TGF‐α‐induced migration of HuH7 cells. Taken together, our results strongly suggest that duloxetine strengthens the TGF‐α‐induced activation of JNK via inhibition of serotonin reuptake in HCC cells, leading to the enhancement of cell migration.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansDuloxetine HydrochlorideFluvoxamineJNK Mitogen-Activated Protein KinasesNorepinephrinep38 Mitogen-Activated Protein KinasesPhosphorylationProto-Oncogene Proteins c-aktSerotoninSertralineTransforming Growth Factor alphaUp-Regulation

Author keywords

HCCJNKTGF-αduloxetinemigrationserotonin transporter

Substances

Duloxetine HydrochlorideFluvoxamineJNK Mitogen-Activated Protein KinasesNorepinephrinep38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktSerotoninSertralineTransforming Growth Factor alpha

Authors and institutions

  • Department of Pharmacology, Graduate School of Medicine, Gifu University, Gifu, Gifu Prefecture, Japan.

Funding

  • Japan Society for the Promotion of Science

Cite

APA

Matsushima-Nishiwaki, R., Kamoi, S., & Kozawa, O. (2023). Upregulation by duloxetine of the transforming growth factor‐α‐induced migration of hepatocellular carcinoma cells via enhancement of the c‐ Jun N‐terminal kinase activity. Cell Biochemistry and Function, 41(7), 814-822. https://doi.org/10.1002/cbf.3831

Vancouver

Matsushima-Nishiwaki R, Kamoi S, Kozawa O. Upregulation by duloxetine of the transforming growth factor‐α‐induced migration of hepatocellular carcinoma cells via enhancement of the c‐ Jun N‐terminal kinase activity. Cell Biochemistry and Function. 2023;41(7):814-822. doi:10.1002/cbf.3831

BibTeX
@article{MatsushimaNishiwaki2023,
  author = {Matsushima-Nishiwaki, Rie and Kamoi, Shota and Kozawa, Osamu},
  title = {Upregulation by duloxetine of the transforming growth factor‐α‐induced migration of hepatocellular carcinoma cells via enhancement of the c‐ Jun N‐terminal kinase activity},
  journal = {Cell Biochemistry and Function},
  year = {2023},
  volume = {41},
  number = {7},
  pages = {814--822},
  doi = {10.1002/cbf.3831}
}
Start for free →